Search research articles
Contact Us
Filters
Showing results (471-480 of 978) with videos related to
Page
of 98
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2012
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma
Jean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma, et al.
Neoplasia (New York, N.Y.)
|
December 19, 2009
Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells
Roya Navab, Jiang Liu, Isolde Seiden-Long, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2021
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
E A Klein, D Richards, A Cohn, et al.
Journal of Racial and Ethnic Health Disparities
|
January 12, 2026
Associations Between Stigma, Discrimination, and HIV Continuum of Care Outcomes Among Criminal Legal-Involved Youth and Young Adults with HIV
Russell A Brewer, Ellen Almirol, Mayra Malagon, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 1, 2018
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity
Peter De Boer, Wayne C Drevets, Hany Rofael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2006
Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission
René H Verheijen, Leon F Massuger, Benedict B Benigno, et al.
Gynecologic Oncology
|
February 16, 2019
Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin
C N Krasner, C Castro, R T Penson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Xiaoji Chen, Zhao Dong, Earl Hubbell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 10, 2001
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
R. T. Penson, K. Kronish, Z. Duan, et al.
Urology
|
October 24, 2021
NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing
Benjamin Seiden, Stanley Weng, Natalie Sun, et al.
Page
of 98
Search research articles
Search
Showing results (471-480 of 978) with videos related to
Sort By:
Page
of 98
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2012
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma
Jean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma, et al.
Neoplasia (New York, N.Y.)
|
December 19, 2009
Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells
Roya Navab, Jiang Liu, Isolde Seiden-Long, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2021
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
E A Klein, D Richards, A Cohn, et al.
Journal of Racial and Ethnic Health Disparities
|
January 12, 2026
Associations Between Stigma, Discrimination, and HIV Continuum of Care Outcomes Among Criminal Legal-Involved Youth and Young Adults with HIV
Russell A Brewer, Ellen Almirol, Mayra Malagon, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 1, 2018
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity
Peter De Boer, Wayne C Drevets, Hany Rofael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2006
Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission
René H Verheijen, Leon F Massuger, Benedict B Benigno, et al.
Gynecologic Oncology
|
February 16, 2019
Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin
C N Krasner, C Castro, R T Penson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Xiaoji Chen, Zhao Dong, Earl Hubbell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 10, 2001
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
R. T. Penson, K. Kronish, Z. Duan, et al.
Urology
|
October 24, 2021
NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing
Benjamin Seiden, Stanley Weng, Natalie Sun, et al.
Page
of 98